Source: Canadian Agency for Drugs and Technologies in Health (CADTH)
Area: News
This rapid review by the Canadian Agency for Drugs and Technologies in Health (CADTH) reviews recommendations on the treatment in patients (including pregnant women) with opioid dependence from evidence-based guidelines, with a special interest in the recommendations for treatment of opioid dependence in small clinic settings, rural area and remote communities.
The key message of the review is that “evidence-based guidelines indicate that opioid dependent patients should be assessed with the DSM-IV-TR diagnostic criteria. Methadone maintenance treatment was recommended as a standard treatment for opioid dependence including pregnant opioid-dependent women. Recommendations state that detoxification s…
CADTH: Review of opioid dependence treatment guidelines
Previous post: When the rubber meets the road: Predicting how parity will affect access to substance abuse services and costs